These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31288417)

  • 41. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
    Budde M; Morr M; Schmid RD; Urlacher VB
    Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons.
    Carmichael AB; Wong LL
    Eur J Biochem; 2001 May; 268(10):3117-25. PubMed ID: 11358532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
    Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
    Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
    Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
    Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
    Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
    [No Abstract]   [Full Text] [Related]  

  • 49. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
    Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
    Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rational re-design of the substrate binding site of flavocytochrome P450 BM3.
    Ost TW; Miles CS; Murdoch J; Cheung Y; Reid GA; Chapman SK; Munro AW
    FEBS Lett; 2000 Dec; 486(2):173-7. PubMed ID: 11113461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
    Neeli R; Roitel O; Scrutton NS; Munro AW
    J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regio- and stereo-selective 1β-hydroxylation of lithocholic acid by cytochrome P450 BM3 mutants.
    Li H; Dai W; Qin S; Li S; Yu Y; Zhang L
    Biotechnol Bioeng; 2023 Aug; 120(8):2230-2241. PubMed ID: 37424513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
    Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
    Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
    Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
    Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.
    Thistlethwaite S; Jeffreys LN; Girvan HM; McLean KJ; Munro AW
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional saturation mutagenesis as an approach to identification of substrate specificity determinants in cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):409S. PubMed ID: 8131983
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst.
    Li HM; Mei LH; Urlacher VB; Schmid RD
    Appl Biochem Biotechnol; 2008 Jan; 144(1):27-36. PubMed ID: 18415984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineering cytochrome P450 BM3 of Bacillus megaterium for terminal oxidation of palmitic acid.
    Brühlmann F; Fourage L; Ullmann C; Haefliger OP; Jeckelmann N; Dubois C; Wahler D
    J Biotechnol; 2014 Aug; 184():17-26. PubMed ID: 24833423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.